Janux Therapeutics, Inc. (JANX) › Shareholders' EquityJanux Therapeutics, Inc. (JANX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$7.94M2020: -$14.64M2021: $366.33M2022: $320.74M2023: $344.35M2024: $1.02B2025: $956.82M$956.82M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$956.82M-6.4%2024$1.02B+197.0%2023$344.35M+7.4%2022$320.74M-12.4%2021$366.33M+2602.6%2020-$14.64M-84.3%2019-$7.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share